Variations in survival and perioperative complications between hospitals based on data from two phase III clinical trials for oesophageal cancer.
about
Inter-institutional survival heterogeneity in chemoradiation therapy for esophageal cancer: exploratory analysis of the JCOG0303 studyPsoralidin inhibits proliferation and enhances apoptosis of human esophageal carcinoma cells via NF-κB and PI3K/Akt signaling pathways.Recent advancements in esophageal cancer treatment in Japan.
P2860
Variations in survival and perioperative complications between hospitals based on data from two phase III clinical trials for oesophageal cancer.
description
2015 nî lūn-bûn
@nan
2015 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Variations in survival and per ...... trials for oesophageal cancer.
@ast
Variations in survival and per ...... trials for oesophageal cancer.
@en
type
label
Variations in survival and per ...... trials for oesophageal cancer.
@ast
Variations in survival and per ...... trials for oesophageal cancer.
@en
prefLabel
Variations in survival and per ...... trials for oesophageal cancer.
@ast
Variations in survival and per ...... trials for oesophageal cancer.
@en
P2093
P2860
P356
P1476
Variations in survival and per ...... trials for oesophageal cancer.
@en
P2093
J Mizusawa
K Nakamura
Y Kitagawa
P2860
P304
P356
10.1002/BJS.9839
P407
P577
2015-06-11T00:00:00Z